HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Small early study suggests GLP-1 drug may cut migraine days even without weight loss

Louis Nervegna · Jun 22, 2025 · ♥ 7 reactions · 1 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Brain health & dementia
AI summary & key facts

A brief post sharing a news report on a small, early-stage study in the journal Headache suggesting a GLP-1 receptor agonist may ease migraines, possibly by lowering pressure in the brain. Louis adds only a one-line comment, and the evidence is preliminary.

GLP-1 agonists may treat migraines.

#glp1HD #headachesHD

Research cited

Shared from ABC News · original post

Drugs in the same family as Ozempic and Wegovy are known for treating diabetes and helping with weight loss, but a small, early-stage study suggested they might also ease migraines — even when there's no weight loss.

← newer: Statins lowered hsCRP by about 1 mg/L in a meta-analysis of older: Coronary CT angiography modestly improved lifestyle and ther →